Literature DB >> 15014978

Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis.

Justin P Rubio1, Melanie Bahlo, Niall Tubridy, Jim Stankovich, Rachel Burfoot, Helmut Butzkueven, Caron Chapman, Laura Johnson, Mark Marriott, Grant Mraz, Brian Tait, Chris Wilkinson, Bruce Taylor, Terence P Speed, Simon J Foote, Trevor J Kilpatrick.   

Abstract

In order to resolve a multiple sclerosis (MS) susceptibility locus that we had identified in earlier work at the telomeric end of the HLA complex, we genotyped another 34 microsatellite markers (47 in total) across the class I/extended class I region in 166 Tasmanian MS case and 104 control families (D6S299-D6S265). Extended MS susceptibility haplotypes, up to 9 Mb in length, were observed in 11% of MS cases and 4% of controls. Direct comparison of the telomerically extended portion of the MS susceptibility haplotype in HFE-Cys282Tyr (C282Y)-homozygous haemochromatosis patients identified a common ancestry for this genomic segment, which translated into an increased frequency of the C282Y allele in 489 MS cases from Tasmania and Victoria (10.2%) compared with controls (6.7%). Six C282Y homozygotes (1.2%), a three-fold increased rate over the general population, and 88 heterozygotes (18%) were identified. One C282Y-homozygous female was identified who had MS and was being treated for symptoms of iron overload. Interestingly, for 71 Victorian MS cases not of north western European (NWE) ancestry, a DR15-independent reduction in the frequency of the C282Y allele was observed, supporting the theory of a NWE origin for the C282Y-variant of the DR15 ancestral haplotype (C282Y-HLA-A*0301-B*0702-DRB1*1501-DQB1*0602). The results of linkage disequilibrium (LD) and log linear modelling analyses suggest that C282Y is increased in MS cases of NWE ancestry because it is in LD with the ancestral DR15 susceptibility haplotype (7.1) and that it does not play an independent role in predisposition to MS. However, our findings provide the impetus for further investigations into the role of iron metabolism in the severity of MS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15014978     DOI: 10.1007/s00439-004-1095-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  34 in total

1.  GOLD--graphical overview of linkage disequilibrium.

Authors:  G R Abecasis; W O Cookson
Journal:  Bioinformatics       Date:  2000-02       Impact factor: 6.937

2.  Further characterization of MHC haplotypes demonstrates conservation telomeric of HLA-A: update of the 4AOH and 10IHW cell panels.

Authors:  S K Cattley; J F Williamson; G K Tay; O P Martinez; S Gaudieri; R L Dawkins
Journal:  Eur J Immunogenet       Date:  2000 Oct-Dec

3.  Global prevalence of putative haemochromatosis mutations.

Authors:  A T Merryweather-Clarke; J J Pointon; J D Shearman; K J Robson
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

4.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

5.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

6.  Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes.

Authors:  R S Ajioka; L B Jorde; J R Gruen; P Yu; D Dimitrova; J Barrow; E Radisky; C Q Edwards; L M Griffen; J P Kushner
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

7.  The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression.

Authors:  J N Feder; Z Tsuchihashi; A Irrinki; V K Lee; F A Mapa; E Morikang; C E Prass; S M Starnes; R K Wolff; S Parkkila; W S Sly; R C Schatzman
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

8.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients.

Authors:  R Bakshi; J Dmochowski; Z A Shaikh; L Jacobs
Journal:  J Neurol Sci       Date:  2001-03-15       Impact factor: 3.181

9.  Transferrin receptor is negatively modulated by the hemochromatosis protein HFE: implications for cellular iron homeostasis.

Authors:  L Salter-Cid; A Brunmark; Y Li; D Leturcq; P A Peterson; M R Jackson; Y Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 10.  Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease.

Authors:  R Dawkins; C Leelayuwat; S Gaudieri; G Tay; J Hui; S Cattley; P Martinez; J Kulski
Journal:  Immunol Rev       Date:  1999-02       Impact factor: 12.988

View more
  17 in total

1.  Detecting genome wide haplotype sharing using SNP or microsatellite haplotype data.

Authors:  Melanie Bahlo; Jim Stankovich; Terence P Speed; Justin P Rubio; Rachel K Burfoot; Simon J Foote
Journal:  Hum Genet       Date:  2005-12-14       Impact factor: 4.132

2.  On the utility of data from the International HapMap Project for Australian association studies.

Authors:  Jim Stankovich; Charles J Cox; Rachel B Tan; Douglas S Montgomery; Stewart J Huxtable; Justin P Rubio; Margaret G Ehm; Laura Johnson; Helmut Butzkueven; Trevor J Kilpatrick; Terence P Speed; Allen D Roses; Melanie Bahlo; Simon J Foote
Journal:  Hum Genet       Date:  2006-01-11       Impact factor: 4.132

3.  Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.

Authors:  Justin P Rubio; Melanie Bahlo; Jim Stankovich; Rachel K Burfoot; Laura J Johnson; Stewart Huxtable; Helmut Butzkueven; Ling Lin; Bruce V Taylor; Terence P Speed; Trevor J Kilpatrick; Emmanuel Mignot; Simon J Foote
Journal:  Immunogenetics       Date:  2007-01-26       Impact factor: 2.846

4.  Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis.

Authors:  Maritha J Kotze; J Nico P de Villiers; Louise Warnich; Stephen Schmidt; Jonathan Carr; Erna Mansvelt; Elba Fourie; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2006-07-19       Impact factor: 3.584

5.  Lack of association between C282Y and H63D polymorphisms in the hemochromatosis gene and risk of multiple sclerosis: A meta-analysis.

Authors:  Nada Starčević Čizmarević; Božena Ćurko-Cofek; Vesna Barac-Latas; Borut Peterlin; Smiljana Ristić
Journal:  Biomed Rep       Date:  2021-12-17

6.  Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.

Authors:  D R Booth; A T Arthur; S M Teutsch; C Bye; J Rubio; P J Armati; J D Pollard; R N S Heard; G J Stewart
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

Review 7.  The conundrum of iron in multiple sclerosis--time for an individualised approach.

Authors:  Susan J van Rensburg; Maritha J Kotze; Ronald van Toorn
Journal:  Metab Brain Dis       Date:  2012-03-17       Impact factor: 3.584

Review 8.  The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis.

Authors:  Paolo Zamboni
Journal:  J R Soc Med       Date:  2006-11       Impact factor: 18.000

9.  Glutamate-mediated primary somatosensory cortex excitability correlated with circulating copper and ceruloplasmin.

Authors:  Franca Tecchio; Giovanni Assenza; Filippo Zappasodi; Stefania Mariani; Carlo Salustri; Rosanna Squitti
Journal:  Int J Alzheimers Dis       Date:  2011-11-21

10.  Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.

Authors:  Donato Gemmati; Giulia Zeri; Elisa Orioli; Francesca E De Gaetano; Fabrizio Salvi; Ilaria Bartolomei; Sandra D'Alfonso; Claudia Dall'osso; Maurizio A Leone; Ajay V Singh; Rosanna Asselta; Paolo Zamboni
Journal:  BMC Med Genet       Date:  2012-08-10       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.